Formation Bio
The pharma company of the future.
New York, United States · Founded 2016 · $372.0M raised
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- formation.bio
- Total Funding
- $372.0M
- Last Round
- $372.0M Series DJun 2024
- Rounds
- 1
About
Formation Bio is a tech-driven, AI-native pharma company that acquires clinical-stage drug candidates from pharma companies, universities, and biotech firms and develops them faster using a proprietary AI platform. The platform automates drug selection via knowledge graphs, clinical trial design, patient recruitment through GenAI tools, and study monitoring, enabling treatments to reach patients faster than traditional drug development.
Summary
Formation Bio is an Artificial Intelligence company based in New York, United States, founded in 2016. It has raised $372.0M in total across 1 round, most recently a $372.0M Series D round in Jun 2024. Investors include Andreessen Horowitz, Sequoia Capital and Thrive Capital.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company